Press release
RNAi for Therapeutic Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2026|Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead
Key companies operating in the global RNAi for Therapeutic market include _Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharma, miRagen Therapeutics, Sylentis, Gradalis, Sirnaomics, Silenseed
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form/1421325/global-rnai-for-therapeutic-market
Segmental Analysis
The report has classified the global RNAi for Therapeutic industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the RNAi for Therapeutic manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall RNAi for Therapeutic industry.
Global RNAi for Therapeutic Market Segment By Type:
RNA, siRNA, miRNA, shRNA
Global RNAi for Therapeutic Market Segment By Application:
Cancer, Cardiovascular, HBV, Other
Competitive Landscape
It is important for every market participant to be familiar with the competitive scenario in the global RNAi for Therapeutic industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key companies operating in the global RNAi for Therapeutic market include _Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharma, miRagen Therapeutics, Sylentis, Gradalis, Sirnaomics, Silenseed
Key questions answered in the report:
What is the growth potential of the RNAi for Therapeutic market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in RNAi for Therapeutic industry in the years to come?
What are the key challenges that the global RNAi for Therapeutic market may face in future?
Which are the leading companies in the global RNAi for Therapeutic market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global RNAi for Therapeutic market?
Enquire Customization in The Report: https://www.qyresearch.com/customize-request/form/1421325/global-rnai-for-therapeutic-market
TOC
Table of Contents 1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNAi for Therapeutic Revenue
1.4 Market Analysis by Type
1.4.1 Global RNAi for Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 siRNA
1.4.3 miRNA
1.4.4 shRNA
1.5 Market by Application
1.5.1 Global RNAi for Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Cardiovascular
1.5.4 HBV
1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions
2.1 RNAi for Therapeutic Market Perspective (2015-2026)
2.2 RNAi for Therapeutic Growth Trends by Regions
2.2.1 RNAi for Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNAi for Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 RNAi for Therapeutic Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 RNAi for Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key RNAi for Therapeutic Players (Opinion Leaders) 3 Competition Landscape by Key Players
3.1 Global Top RNAi for Therapeutic Players by Market Size
3.1.1 Global Top RNAi for Therapeutic Players by Revenue (2015-2020)
3.1.2 Global RNAi for Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNAi for Therapeutic Market Concentration Ratio
3.2.1 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNAi for Therapeutic Revenue in 2019
3.3 RNAi for Therapeutic Key Players Head office and Area Served
3.4 Key Players RNAi for Therapeutic Product Solution and Service
3.5 Date of Enter into RNAi for Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)
4.1 Global RNAi for Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global RNAi for Therapeutic Forecasted Market Size by Type (2021-2026) 5 RNAi for Therapeutic Breakdown Data by Application (2015-2026)
5.1 Global RNAi for Therapeutic Market Size by Application (2015-2020)
5.2 Global RNAi for Therapeutic Forecasted Market Size by Application (2021-2026) 6 North America
6.1 North America RNAi for Therapeutic Market Size (2015-2020)
6.2 RNAi for Therapeutic Key Players in North America (2019-2020)
6.3 North America RNAi for Therapeutic Market Size by Type (2015-2020)
6.4 North America RNAi for Therapeutic Market Size by Application (2015-2020) 7 Europe
7.1 Europe RNAi for Therapeutic Market Size (2015-2020)
7.2 RNAi for Therapeutic Key Players in Europe (2019-2020)
7.3 Europe RNAi for Therapeutic Market Size by Type (2015-2020)
7.4 Europe RNAi for Therapeutic Market Size by Application (2015-2020) 8 China
8.1 China RNAi for Therapeutic Market Size (2015-2020)
8.2 RNAi for Therapeutic Key Players in China (2019-2020)
8.3 China RNAi for Therapeutic Market Size by Type (2015-2020)
8.4 China RNAi for Therapeutic Market Size by Application (2015-2020) 9 Japan
9.1 Japan RNAi for Therapeutic Market Size (2015-2020)
9.2 RNAi for Therapeutic Key Players in Japan (2019-2020)
9.3 Japan RNAi for Therapeutic Market Size by Type (2015-2020)
9.4 Japan RNAi for Therapeutic Market Size by Application (2015-2020) 10 Southeast Asia
10.1 Southeast Asia RNAi for Therapeutic Market Size (2015-2020)
10.2 RNAi for Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNAi for Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia RNAi for Therapeutic Market Size by Application (2015-2020) 11 India
11.1 India RNAi for Therapeutic Market Size (2015-2020)
11.2 RNAi for Therapeutic Key Players in India (2019-2020)
11.3 India RNAi for Therapeutic Market Size by Type (2015-2020)
11.4 India RNAi for Therapeutic Market Size by Application (2015-2020) 12 Central & South America
12.1 Central & South America RNAi for Therapeutic Market Size (2015-2020)
12.2 RNAi for Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America RNAi for Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America RNAi for Therapeutic Market Size by Application (2015-2020) 13Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma (Tekmira)
13.2.1 Arbutus Biopharma (Tekmira) Company Details
13.2.2 Arbutus Biopharma (Tekmira) Business Overview and Its Total Revenue
13.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Introduction
13.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2015-2020)
13.2.5 Arbutus Biopharma (Tekmira) Recent Development
13.3 Arrowhead
13.3.1 Arrowhead Company Details
13.3.2 Arrowhead Business Overview and Its Total Revenue
13.3.3 Arrowhead RNAi for Therapeutic Introduction
13.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2015-2020)
13.3.5 Arrowhead Recent Development
13.4 Dicerna Pharmaceuticals
13.4.1 Dicerna Pharmaceuticals Company Details
13.4.2 Dicerna Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Introduction
13.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.4.5 Dicerna Pharmaceuticals Recent Development
13.5 Mirna Therapeutics
13.5.1 Mirna Therapeutics Company Details
13.5.2 Mirna Therapeutics Business Overview and Its Total Revenue
13.5.3 Mirna Therapeutics RNAi for Therapeutic Introduction
13.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.5.5 Mirna Therapeutics Recent Development
13.6 Quark Pharmaceuticals
13.6.1 Quark Pharmaceuticals Company Details
13.6.2 Quark Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Quark Pharmaceuticals RNAi for Therapeutic Introduction
13.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.6.5 Quark Pharmaceuticals Recent Development
13.7 RXi Pharmaceuticals
13.7.1 RXi Pharmaceuticals Company Details
13.7.2 RXi Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 RXi Pharmaceuticals RNAi for Therapeutic Introduction
13.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.7.5 RXi Pharmaceuticals Recent Development
13.8 Silence Therapeutics
13.8.1 Silence Therapeutics Company Details
13.8.2 Silence Therapeutics Business Overview and Its Total Revenue
13.8.3 Silence Therapeutics RNAi for Therapeutic Introduction
13.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.8.5 Silence Therapeutics Recent Development
13.9 Benitec Biopharma
13.9.1 Benitec Biopharma Company Details
13.9.2 Benitec Biopharma Business Overview and Its Total Revenue
13.9.3 Benitec Biopharma RNAi for Therapeutic Introduction
13.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2015-2020)
13.9.5 Benitec Biopharma Recent Development
13.10 miRagen Therapeutics
13.10.1 miRagen Therapeutics Company Details
13.10.2 miRagen Therapeutics Business Overview and Its Total Revenue
13.10.3 miRagen Therapeutics RNAi for Therapeutic Introduction
13.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.10.5 miRagen Therapeutics Recent Development
13.11 Sylentis
10.11.1 Sylentis Company Details
10.11.2 Sylentis Business Overview and Its Total Revenue
10.11.3 Sylentis RNAi for Therapeutic Introduction
10.11.4 Sylentis Revenue in RNAi for Therapeutic Business (2015-2020)
10.11.5 Sylentis Recent Development
13.12 Gradalis
10.12.1 Gradalis Company Details
10.12.2 Gradalis Business Overview and Its Total Revenue
10.12.3 Gradalis RNAi for Therapeutic Introduction
10.12.4 Gradalis Revenue in RNAi for Therapeutic Business (2015-2020)
10.12.5 Gradalis Recent Development
13.13 Sirnaomics
10.13.1 Sirnaomics Company Details
10.13.2 Sirnaomics Business Overview and Its Total Revenue
10.13.3 Sirnaomics RNAi for Therapeutic Introduction
10.13.4 Sirnaomics Revenue in RNAi for Therapeutic Business (2015-2020)
10.13.5 Sirnaomics Recent Development
13.14 Silenseed
10.14.1 Silenseed Company Details
10.14.2 Silenseed Business Overview and Its Total Revenue
10.14.3 Silenseed RNAi for Therapeutic Introduction
10.14.4 Silenseed Revenue in RNAi for Therapeutic Business (2015-2020)
10.14.5 Silenseed Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Contact Us:-
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com
Web:
http://www.qyresearch.com
About Us:-
QY Research is the most reliable source to access the market research reports that will offer you a lead that your business needs. At QY Research, our key objective is to provide a platform for various world-class market research companies across the globe to circulate their research reports. We also assist decision-makers in finding suitable business solutions. QY Research Wire has a primary aim of providing an ultimate solution based on customers' requirements.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi for Therapeutic Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2026|Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead here
News-ID: 1996159 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
